93 related articles for article (PubMed ID: 7911749)
1. Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients.
Amara A; Chaugier C; Ragnaud JM; Geffard M
Clin Exp Immunol; 1994 Jun; 96(3):379-83. PubMed ID: 7911749
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients.
Sadallah S; Hess C; Trendelenburg M; Vedeler C; Lopez-Trascasa M; Schifferli JA
Clin Exp Immunol; 2003 Jan; 131(1):174-81. PubMed ID: 12519402
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients.
Amara A; Chaugier C; Geffard M
AIDS; 1994 May; 8(5):711-3. PubMed ID: 8060557
[No Abstract] [Full Text] [Related]
4. IgA-anti-Fab autoantibodies and disease progression in AIDS.
Süsal C; Daniel V; Doerr C; Zimmermann R; Huth-Kühne A; Opelz G
Immunol Lett; 1993 Apr; 36(1):27-30. PubMed ID: 8102124
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies directed against lipid membrane components in sera of patients with malignant tumors.
Faiderbe S; Chagnaud JL; Charrier MC; Peyron MA; Wafflart J; Geffard M
Cancer Detect Prev; 1991; 15(3):199-203. PubMed ID: 2059961
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity.
Calder PC; Yaqoob P; Harvey DJ; Watts A; Newsholme EA
Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):509-18. PubMed ID: 8002957
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against peripheral blood cells appear early in HIV infection and their prevalence increases with disease progression.
Klaassen RJ; Mulder JW; Vlekke AB; Eeftinck Schattenkerk JK; Weigel HM; Lange JM; von dem Borne AE
Clin Exp Immunol; 1990 Jul; 81(1):11-7. PubMed ID: 1974174
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and specificity of lymphocytotoxic antibodies in different stages of HIV infection.
Szabó B; Tóth FD; Kiss J; Füst G; Ujhelyi E; Bánhegyi D; Horváth A; Hollán SR
Acta Virol; 1992 Aug; 36(4):392-400. PubMed ID: 1362323
[TBL] [Abstract][Full Text] [Related]
10. Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis.
Boullerne A; Petry KG; Geffard M
J Neuroimmunol; 1996 Mar; 65(1):75-81. PubMed ID: 8642067
[TBL] [Abstract][Full Text] [Related]
11. Multiple false-positive reactions in anti-CD4 ELISA testing of dystrophic children.
Apetrei C; Mitroi I; Groll I; Duca M
Rev Med Chir Soc Med Nat Iasi; 1995; 99(3-4):157-61. PubMed ID: 9455361
[TBL] [Abstract][Full Text] [Related]
12. Impaired parathyroid hormone release in human immunodeficiency virus infection.
Hellman P; Albert J; Gidlund M; Klareskog L; Rastad J; Akerström G; Juhlin C
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):391-4. PubMed ID: 7915122
[TBL] [Abstract][Full Text] [Related]
13. Association of T cell dysfunction with the presence of IgG autoantibodies on CD4+ lymphocytes in haemophilia patients; results of a 10-year study.
Daniel V; Süsal C; Weimer R; Zipperle S; Kröpelin M; Zimmermann R; Huth-Kühne A; Opelz G
Clin Exp Immunol; 1996 Apr; 104(1):4-10. PubMed ID: 8603531
[TBL] [Abstract][Full Text] [Related]
14. C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins.
Prohászka Z; Daha MR; Süsal C; Daniel V; Szlávik J; Bánhegyi D; Nagy K; Várkonyi V; Horváth A; Ujhelyi E; Tóth FD; Uray K; Hudecz F; Füst G
Clin Immunol; 1999 Feb; 90(2):247-55. PubMed ID: 10080837
[TBL] [Abstract][Full Text] [Related]
15. Antilactoferrin autoantibodies associated with HIV infection.
Defer MC; Follézou JY; Picard O; Damais C
C R Acad Sci III; 1994 Jul; 317(7):675-8. PubMed ID: 7882152
[TBL] [Abstract][Full Text] [Related]
16. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.
Müller C; Kukel S; Bauer R
Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
[TBL] [Abstract][Full Text] [Related]
18. Nonorgan-specific autoantibodies in individuals infected with type 1 human immunodeficiency virus.
Gentric A; Blaschek M; Julien C; Jouquan J; Pennec Y; Berthelot JM; Mottier D; Casburn-Budd R; Youinou P
Clin Immunol Immunopathol; 1991 Jun; 59(3):487-94. PubMed ID: 1674241
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity.
Niinistö S; Takkinen HM; Erlund I; Ahonen S; Toppari J; Ilonen J; Veijola R; Knip M; Vaarala O; Virtanen SM
Diabetologia; 2017 Jul; 60(7):1223-1233. PubMed ID: 28474159
[TBL] [Abstract][Full Text] [Related]
20. Action of long-chain fatty acids in vitro on Ca2+-stimulatable, Mg2+-dependent ATPase activity in human red cell membranes.
Davis FB; Davis PJ; Blas SD; Schoenl M
Biochem J; 1987 Dec; 248(2):511-6. PubMed ID: 2963620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
